ACE527 Safety and Immunogenicity Study

Clinical trial NCT00901654 · COMPLETED

Trial details

NCT number: NCT00901654
Sponsor: TD Vaccines A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Enterotoxigenic E. Coli (ETEC) Infection

Start date: 2009-06-01
Primary completion: 2009-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.